Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

SUPREFACT

CHEPLAPHARM ARZNEIMITTEL GMBH

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SUPREFACT discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SUPREFACT 100MCG has been permanently discontinued (last updated December 13, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SUPREFACT not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength100MCG
Last updated2021-12-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SUPREFACT INTRANASAL SOLUTION 1MG/ML

HOECHST CANADA INC.

1MG · DIN 00680036

Different strengthDifferent dosage formSame routeNo current shortage

SUPREFACT LIQ 1MG/ML

HOECHST ROUSSEL CANADA INC.

1MG · DIN 01989669

Different strengthDifferent dosage formSame routeNo current shortage

SUPREFACT

CHEPLAPHARM ARZNEIMITTEL GMBH

1MG · DIN 02225166

Different strengthSame dosage formDifferent routeNo current shortage

SUPREFACT INJ 1MG/ML

HOECHST CANADA INC.

1MG · DIN 00680028

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02225158

Strength

100MCG

Dosage Form

SOLUTION

Route

NASAL

Active Ingredient

BUSERELIN

See all BUSERELIN products →

Shortage History